# PREVYMIS

NDC: 0006-5004
Generic name: LETERMOVIR
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20171108

FDA application: NDA209940

## Active ingredients

- LETERMOVIR: 20 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0006-5004"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0006-5004
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1b49df80-be4f-47e0-a0b7-123f3e69395b